BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 207941)

  • 1. The use of adjunctive drugs to alter uptake of 99mTc-Sn-pyrophosphate by myocardial lesions and bone.
    Carr EA; Carroll M; Montes M
    Life Sci; 1978 Apr 3-17; 22(13-15):1261-74. PubMed ID: 207941
    [No Abstract]   [Full Text] [Related]  

  • 2. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 3. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of iron-dextran on the biodistribution of technetium pyrophosphate.
    Choy D; Maddalena DJ; Murray IP
    Int J Nucl Med Biol; 1982; 9(4):277-82. PubMed ID: 7186499
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial uptake of technetium-99m stannous pyrophosphate in experimental viral myopericarditis.
    Kadota K; Matsumori A; Kambara H; Kawai C
    J Nucl Med; 1979 Oct; 20(10):1047-50. PubMed ID: 231641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic comparison of 96Tc-pyrophosphate and 45Ca bone uptake.
    Le Pape A; Guillemart A
    Eur J Nucl Med; 1982; 7(3):127-9. PubMed ID: 7067714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of local heating on the uptake of 99m-technetium labeled pyrophosphate of tin in humans].
    Mortier G; Blockx P; CHappel R
    J Belge Rhumatol Med Phys; 1976; 31(5):256-60. PubMed ID: 1027749
    [No Abstract]   [Full Text] [Related]  

  • 8. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cardioversion of atrial fibrillation result in myocardial damage?
    Metcalfe MJ; Smith F; Jennings K; Paterson N
    Br Med J (Clin Res Ed); 1988 May; 296(6633):1364. PubMed ID: 3134987
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocsrdial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock.
    DiCola VC; Freedman GS; Downing SE; Zaret BL
    Circulation; 1976 Dec; 54(6):980-6. PubMed ID: 991415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of technetium-99m stannous pyrophosphate in contused myocardium.
    Downey J; Chagrasulis R; Fore D; Parmley LF
    J Nucl Med; 1977 Dec; 18(12):1171-5. PubMed ID: 606739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic importance of a positive test of myocardial 99mTc-Sn-pyrophosphate accumulation in patients with stable stenocardia].
    Botnar' VI; Eventov AZ; Lupanov VP
    Kardiologiia; 1983 May; 23(5):44-6. PubMed ID: 6876546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of methods of myocardial scintigraphy using 99mTc-Sn-glucohepatonate and 99mTc-Sn-pyrophosphate in the diagnosis of acute myocardial infarction and unstable stenocardia].
    Stepanova IP; Malyshev IuM
    Kardiologiia; 1984 Mar; 24(3):31-5. PubMed ID: 6727090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m stannous pyrophosphate imaging of experimental infective endocarditis.
    Riba AL; Downs J; Thakur ML; Gottschalk A; Andriole VT; Zaret BL
    Circulation; 1978 Jul; 58(1):111-9. PubMed ID: 656183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.
    Jovanović V; Maksin T; Rastovac M; Bzenić J
    Eur J Nucl Med; 1983; 8(4):179-82. PubMed ID: 6861787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying effect of commercially available stannous pyrophosphate (PYRO-Sn) on the tissue affinity of 99mTc pertechnetate.
    Bałtrukiewicz Z; Przedlacki J; Dziuk E
    Eur J Nucl Med; 1980; 5(1):45-7. PubMed ID: 7379805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of dihydrotachysterol-2 and dihydrotachysterol-3 in chicks.
    Bosmann HB; Chen PS
    J Nutr; 1966 Oct; 90(2):141-7. PubMed ID: 4288461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of vitamin D3, dihydrotachysterol, and parathormone on calcium kinetics in the rat.
    Remagen W; Guncaga J; Lauffenburger T
    Res Exp Med (Berl); 1975 Sep; 165(3):285-90. PubMed ID: 169559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic uptake of 99Tc stannous pyrophosphate in experimental viral pancreatitis in mice.
    Matsumori A; Kadota K; Kawai C
    Eur J Nucl Med; 1981 Apr; 6(4):163-7. PubMed ID: 6260500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.